MEZZALANA, ENRICA
 Distribuzione geografica
Continente #
NA - Nord America 375
EU - Europa 242
AS - Asia 231
SA - Sud America 9
AF - Africa 2
Totale 859
Nazione #
US - Stati Uniti d'America 365
CN - Cina 128
IE - Irlanda 61
SG - Singapore 55
FI - Finlandia 26
RU - Federazione Russa 25
UA - Ucraina 25
HK - Hong Kong 24
SE - Svezia 19
GB - Regno Unito 18
DE - Germania 16
IT - Italia 15
PT - Portogallo 12
BE - Belgio 11
VN - Vietnam 10
BR - Brasile 7
JP - Giappone 6
MX - Messico 5
CA - Canada 4
FR - Francia 4
ES - Italia 3
IN - India 3
AR - Argentina 2
BD - Bangladesh 2
NO - Norvegia 2
PL - Polonia 2
AT - Austria 1
EE - Estonia 1
HU - Ungheria 1
JO - Giordania 1
MA - Marocco 1
MY - Malesia 1
PA - Panama 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 859
Città #
Chandler 64
Dublin 61
Ann Arbor 41
Jacksonville 41
Nanjing 40
Singapore 36
Ashburn 25
Hong Kong 24
Dallas 15
Boardman 14
Wilmington 14
Princeton 13
Changsha 12
Coimbra 12
Nanchang 12
Brussels 11
Helsinki 9
Lawrence 9
Medford 8
Shanghai 8
Beijing 7
Hangzhou 7
Hebei 7
Moscow 7
Shenyang 7
Dearborn 6
Houston 6
Piscataway 6
Falls Church 5
Los Angeles 5
Zhengzhou 5
Pavia 4
Plymouth 4
Redondo Beach 4
Guangzhou 3
Ho Chi Minh City 3
Tokyo 3
Woodbridge 3
Bexley 2
Boston 2
Des Moines 2
Dhaka 2
Hanoi 2
Mexico City 2
Milan 2
Munich 2
Needham 2
Norwalk 2
Nuremberg 2
Oslo 2
Poznan 2
Redwood City 2
San Diego 2
Santa Clara 2
Stockholm 2
The Dalles 2
Tianjin 2
Toronto 2
Villeurbanne 2
Amman 1
Apucarana 1
Benito Juarez 1
Birmingham 1
Biên Hòa 1
Brooklyn 1
Buenos Aires 1
Buffalo 1
Can Tho 1
Carney 1
Celaya 1
Changzhou 1
Chennai 1
Chicago 1
Cleveland 1
Colinas 1
Columbus 1
Fareham 1
Gravataí 1
Jiaxing 1
Johannesburg 1
Kuala Lumpur 1
Laayoune 1
Lanzhou 1
Lauro de Freitas 1
Linfen 1
Manchester 1
Manila 1
New Delhi 1
New York 1
Nova Venécia 1
Orem 1
Poplar 1
Quảng Ngãi 1
Resistencia 1
Rio de Janeiro 1
San Francisco 1
San Jose 1
Seattle 1
Sopron 1
Surat 1
Totale 644
Nome #
A Target-Mediated Drug Disposition model integrated with a T lymphocyte pharmacodynamic model for Otelixizumab. 114
A Target-Mediated Drug Disposition model to quantify the relationship between Otelixizumab in vitro concentration and TCR/CD3 engagement 110
Evaluation of software tools for Bayesian estimation on population models with count and continuous data 104
A Target-Mediated Drug Disposition model to quantify the relationship between Anti-CD3 monoclonal antibody and CD3/TCR receptors in Patients with autoimmune diseases. 103
Temporal pharmacokinetic/pharmacodynamic interaction between human CD3ε antigen-targeted monoclonal antibody otelixizumab and CD3ε binding and expression in human peripheral blood mononuclear cell static culture 100
Automatic translation of Bayesian pharmacometric models: the PharmML-to-WinBugs converter 97
Multinomial Logistic Functions in Markov Chain Models of Sleep Architecture: Internal and External Validation and Covariate Analysis 88
Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development 83
MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issues 74
Totale 873
Categoria #
all - tutte 3.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.642


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 7 6 9 6 12 9 2
2021/202269 2 2 4 2 4 3 4 6 1 7 8 26
2022/2023176 21 21 4 24 13 14 0 5 67 1 4 2
2023/202464 3 10 0 1 18 9 6 1 2 0 11 3
2024/2025134 6 12 0 8 5 8 3 8 39 3 12 30
2025/2026149 20 19 21 19 60 10 0 0 0 0 0 0
Totale 873